том 21 издание 9 страницы 5058-5071

Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals

Тип публикацииJournal Article
Дата публикации2021-07-26
SCImago Q2
WOS Q1
БС1
SJR0.62
CiteScore5.5
Impact factor3.6
ISSN15287483, 15287505
General Chemistry
Condensed Matter Physics
General Materials Science
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

2
4
6
8
10
Crystal Growth and Design
10 публикаций, 50%
CrystEngComm
5 публикаций, 25%
Pharmaceutical Research
1 публикация, 5%
Physical Chemistry Chemical Physics
1 публикация, 5%
European Journal of Pharmaceutical Sciences
1 публикация, 5%
Crystals
1 публикация, 5%
Journal of Molecular Liquids
1 публикация, 5%
2
4
6
8
10

Издатели

2
4
6
8
10
American Chemical Society (ACS)
10 публикаций, 50%
Royal Society of Chemistry (RSC)
6 публикаций, 30%
Elsevier
2 публикации, 10%
Springer Nature
1 публикация, 5%
MDPI
1 публикация, 5%
2
4
6
8
10
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
20
Поделиться
Цитировать
ГОСТ |
Цитировать
Perlovich G. Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals // Crystal Growth and Design. 2021. Vol. 21. No. 9. pp. 5058-5071.
ГОСТ со всеми авторами (до 50) Скопировать
Perlovich G. Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals // Crystal Growth and Design. 2021. Vol. 21. No. 9. pp. 5058-5071.
RIS |
Цитировать
TY - JOUR
DO - 10.1021/acs.cgd.1c00477
UR - https://doi.org/10.1021/acs.cgd.1c00477
TI - Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals
T2 - Crystal Growth and Design
AU - Perlovich, German
PY - 2021
DA - 2021/07/26
PB - American Chemical Society (ACS)
SP - 5058-5071
IS - 9
VL - 21
SN - 1528-7483
SN - 1528-7505
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2021_Perlovich,
author = {German Perlovich},
title = {Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals},
journal = {Crystal Growth and Design},
year = {2021},
volume = {21},
publisher = {American Chemical Society (ACS)},
month = {jul},
url = {https://doi.org/10.1021/acs.cgd.1c00477},
number = {9},
pages = {5058--5071},
doi = {10.1021/acs.cgd.1c00477}
}
MLA
Цитировать
Perlovich, German. “Two-Component Molecular Crystals: What Is the Difference between Drug–Drug, Drug–GRAS, and CF–CF Databases? Evaluation of Melting Points and Ideal Solubility of Unknown Co-crystals.” Crystal Growth and Design, vol. 21, no. 9, Jul. 2021, pp. 5058-5071. https://doi.org/10.1021/acs.cgd.1c00477.
Ошибка в публикации?